BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1105 related articles for article (PubMed ID: 17413266)

  • 1. Ethical issues in the NIMH Collaborative HIV/STD Prevention Trial.
    NIMH Collaborative HIV/STD Prevention Trial Group
    AIDS; 2007 Apr; 21 Suppl 2():S69-80. PubMed ID: 17413266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of populations represented in the NIMH Collaborative HIV/STD Prevention Trial.
    NIMH Collaborative HIV/STD Prevention Trial Group
    AIDS; 2007 Apr; 21 Suppl 2():S19-28. PubMed ID: 17413260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the data safety and monitoring board in an international trial.
    NIMH Collaborative HIV/STD Prevention Trial
    AIDS; 2007 Apr; 21 Suppl 2():S99-102. PubMed ID: 17413269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexually transmitted disease and HIV prevalence and risk factors in concentrated and generalized HIV epidemic settings.
    NIMH Collaborative HIV/STD Prevention Trial Group
    AIDS; 2007 Apr; 21 Suppl 2():S81-90. PubMed ID: 17413267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formative study conducted in five countries to adapt the community popular opinion leader intervention.
    NIMH Collaborative HIV/STD Prevention Trial Group
    AIDS; 2007 Apr; 21 Suppl 2():S91-8. PubMed ID: 17413268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The community popular opinion leader HIV prevention programme: conceptual basis and intervention procedures.
    NIMH Collaborative HIV/STD Prevention Trial Group
    AIDS; 2007 Apr; 21 Suppl 2():S59-68. PubMed ID: 17413265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and concepts of the NIMH Collaborative HIV/STD Prevention Trial.
    van Griensven F; Kalichman SC
    AIDS; 2007 Apr; 21 Suppl 2():S1-2. PubMed ID: 17413257
    [No Abstract]   [Full Text] [Related]  

  • 8. Methodological overview of a five-country community-level HIV/sexually transmitted disease prevention trial.
    NIMH Collaborative HIV/STD Prevention Trial Group
    AIDS; 2007 Apr; 21 Suppl 2():S3-18. PubMed ID: 17413262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges and processes of selecting outcome measures for the NIMH Collaborative HIV/STD Prevention Trial.
    NIMH Collaborative HIV/STD Prevention Trial Group
    AIDS; 2007 Apr; 21 Suppl 2():S29-36. PubMed ID: 17413261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The feasibility of audio computer-assisted self-interviewing in international settings.
    NIMH Collaborative HIV/STD Prevention Trial Group
    AIDS; 2007 Apr; 21 Suppl 2():S49-58. PubMed ID: 17413264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Building community partnerships: case studies of Community Advisory Boards at research sites in Peru, Zimbabwe, and Thailand.
    Morin SF; Morfit S; Maiorana A; Aramrattana A; Goicochea P; Mutsambi JM; Robbins JL; Richards TA
    Clin Trials; 2008; 5(2):147-56. PubMed ID: 18375653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and integration of ethnography within an international behavior change HIV/sexually transmitted disease prevention trial.
    NIMH Collaborative HIV/STD Prevention Trial Group
    AIDS; 2007 Apr; 21 Suppl 2(Suppl 2):S37-48. PubMed ID: 17413263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An approach to addressing ethical issues in a community-based risk assessment for HIV: a case from Chennai, India.
    Sivaram S; Srikrishnan AK; Murgavel KG; Mayer KH; Anand S; Celentano DD; Solomon S
    J Health Popul Nutr; 2005 Jun; 23(2):165-76. PubMed ID: 16117369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIDS research in developing countries: do the ends justify the means?
    Clark PA
    Med Sci Monit; 2002 Sep; 8(9):ED5-16. PubMed ID: 12218951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endpoints and other measures in a multisite HIV prevention trial: rationale and psychometric properties. NIMH Multisite HIV Prevention Trial.
    AIDS; 1997 Dec; 11 Suppl 2():S37-47. PubMed ID: 9475710
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessing social risks prior to commencement of a clinical trial: due diligence or ethical inflation?
    Burris S; Davis C
    Am J Bioeth; 2009 Nov; 9(11):48-54. PubMed ID: 19882460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collecting sexually transmitted disease clinic chart data in multisite studies. NIMH Multisite HIV Prevention Trial.
    AIDS; 1997 Dec; 11 Suppl 2():S59-63. PubMed ID: 9475713
    [No Abstract]   [Full Text] [Related]  

  • 18. Microbicide research in developing countries: have we given the ethical concerns due consideration?
    Moodley K
    BMC Med Ethics; 2007 Sep; 8():10. PubMed ID: 17877834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reporting of informed consent, standard of care and post-trial obligations in global randomized intervention trials: a systematic survey of registered trials.
    Cohen ER; O'Neill JM; Joffres M; Upshur RE; Mills E
    Dev World Bioeth; 2009 Aug; 9(2):74-80. PubMed ID: 18445072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical experimentation with HIV vaccines: scientific and ethical dilemmas].
    Lallemant M; Le Coeur S
    Hist Philos Life Sci; 1995; 17(1):151-69. PubMed ID: 8552748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.